BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Kidney cancer\, or renal cell carcinoma (RCC)\, is one of the 
 10 most common cancers in the US. In 2024\, more than 81\,000 people were
  diagnosed with RCC. Localized renal masses (LRM\, tumors confined to the
  kidney) make up two-thirds of all RCC. There are four way to manage LRMs
 : active surveillance\, ablation\, partial nephrectomy and radical nephre
 ctomy. Current recommendations are based on 'expert opinion' and it is ty
 pically left up to the doctor to decide what is the best for the patient 
 in terms of risk to the kidney and whether the cancer threatens the life 
 of the patient over other medical conditions the patient may have. Dr. Lo
 bo will present a Markov decision process (MDP) model framework for optim
 izing treatment decision making for patients with LRM. She will present p
 reliminary MDP results along with findings from ancillary studies. Jennif
 er Lobo is an Associate Professor in the Department of Public Health Scie
 nces in the School of Medicine at the University of Virginia (UVA)\, with
  courtesy appointments in the Department of Urology and the Department of
  Systems and Information Engineering at UV A. She received her B.Sc. in M
 athematics from the University of South Carolina\, her M.Sc. in Operation
 s Research from North Carolina State University (NCSU)\, and her Ph.D. in
  Industrial Engineering from NCSU. Her research primarily involves using 
 Markov models\, Markov decision processes\, and simulation to inform scre
 ening\, treatment\, and policy decisions for patients with chronic condit
 ions\, including kidney cancer\, type 2 diabetes\, and multiple sclerosis
 . Her work is currently supported by the National Institutes of Health an
 d the Department of Defense\, with additional previous support from the A
 gency for Healthcare Research and Quality\, the National Science Foundati
 on\, and the American Cancer Society. Dr. Lobo currently serves as an Ass
 ociate Editor for Health Care Management Science and Area Editor for Math
 ematical Modelling for Health Systems.\n\nSpeaker:\nJennifer Lobo\, PhD\n
 \nAdmission:\nFree\n\nFood:\nlunch provided for those registered for the 
 seminar\n\nDetails URL:\nhttps://medicine.yale.edu/event/modeling-seminar
 -february/\n
DTEND;TZID=America/New_York:20250224T130000
DTSTAMP:20261030T151314Z
DTSTART;TZID=America/New_York:20250224T120000
GEO:41.302961;-72.931638
LOCATION:106A\, 47 College Street\, New Haven\, CT\, United States
SEQUENCE:0
STATUS:Confirmed
SUMMARY:Seminar in Public Health Modeling
UID:e49fe2d7-5938-4c4e-9502-a309694699bc
END:VEVENT
END:VCALENDAR